La Jolla Lab Teams With Israel In High-Stakes Hunt For Super Vaccine Targets
La Jolla Institute researchers joined a PNAS study that introduced "superHLA," a computational pipeline that scanned more than 190,000 peptides and validated 24 superbinders. The method could help identify vaccine targets that work across diverse genetic backgrounds.












